MUMBAI (NewsRise) -- The uncontained spread of the new coronavirus poses a fresh threat to the profitability of Indian drug makers, whose inventory of pharmaceutical ingredients may barely last for two more months.
Pharmaceuticals
Indian drugmakers may suffer profit drop as coronavirus threatens China supplies
Inventory of pharmaceutical ingredients may barely last for two more months
Most companies such as Sun Pharmaceutical Industries and Cipla are well stocked up with inventory up until the first quarter. © Reuters
Latest on Pharmaceuticals
